The decision in the case came from the UK self-regulatory body of the pharmaceutical industry the PMPCA (Prescription Medicines Code of Practice Authority), which imposed our marketing company Orion Pharma (UK) Ltd a sanction fee of GBP partners in the marketing of Easyhaler products.